Implementation of Internet-Based Psychotherapy for OCD in Primary Health Care in Two Cities in the State of São Paulo
- Sponsor
- University of Sao Paulo General Hospital
- Study ID
- NCT06658756
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Obsessive-Compulsive Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- internet-CBT — BEHAVIORAL10 modules on line of I-CBT for OCD
Study Details
The aim of this study is to assess the implementation of Internet-based Cognitive Behavioral Therapy (I-CBT) treatment in a Brazilian sample. Researchers will compare 140 participants (70 with I-CBT and 70 in usual care to see if the treatment is feasible. Participants will undergo online treatment for OCD, lasting 10 to 14 weeks.
Key Dates
- First listed
- Oct 26, 2024
- Start date
- Jan 31, 2025
- Status verified
- Aug 2024
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 140 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: I-CBTInternet cognitive-behavioral therapy
- No Intervention: TUTreatment as Usual
Primary Outcome Measure
Y-BOCS [ Time Frame: From enrollment to the end of treatment at 10 weeks. 3 and 12 months after end of treatment ]
Related Studies
- Locating Biomarkers in OCD Through Behavioral TasksNot Yet Recruiting · Baylor College of Medicine · Pittsburgh, Pennsylvania
- Efficacy of Nitrous Oxide in OCD: Pilot StudyPHASE2 · Recruiting · Stanford University · Stanford, California
- Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum DisordersRecruiting · Stanford University · Stanford, California
- Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCDPHASE1/PHASE2 · Recruiting · Yale University · New Haven, Connecticut